Inventor · disambiguated record
Shankar Kumar
Also filed as: KUMAR SHANKAR · KUNWAR SHANKAR
31 granted patents·7 pending applications·606 citations·filing 2004–2023
97Inventor score
Top patents by PatentIndex Score
38 records- 0197US9163085B2Anti-OX40 antibodies and methods of treating cancerLIU YONG-JUN·Filed 2012·Granted Oct 20, 2015·94 cites·7 claims
- 0297US9006399B2Anti-OX40 antibodies and methods of using the sameLIU YONG-JUN·Filed 2011·Granted Apr 14, 2015·114 cites·9 claims
- 0397US7915388B2Interleukin-13 binding proteinsABBOTT LAB·Filed 2007·Granted Mar 29, 2011·96 cites·41 claims
- 0495US7700739B2IL-12/p40 binding proteinsABBOTT LAB·Filed 2006·Granted Apr 20, 2010·57 cites·117 claims
- 0594US7255846B2Methods for synthesis of semiconductor nanocrystals and thermoelectric compositionsTRUSTEES BOSTON COLLEGE·Filed 2005·Granted Aug 14, 2007·26 cites·33 claims
- 0693US9527917B2Nucleic acid encoding anti-OX40 antibodiesUNIV TEXAS·Filed 2015·Granted Dec 27, 2016·12 cites·17 claims
- 0793US7586033B2Metal-doped semiconductor nanoparticles and methods of synthesis thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Sep 8, 2009·16 cites·8 claims
- 0892US9695246B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2015·Granted Jul 4, 2017·10 cites·9 claims
- 0992US9592293B2Interleukin-13 binding proteinsABBVIE INC·Filed 2013·Granted Mar 14, 2017·18 cites·13 claims
- 1092US9427464B2Anti-human TROP-2 antibody having an antitumor activity in vivoLIVTECH INC·Filed 2012·Granted Aug 30, 2016·35 cites·10 claims
- 1191US9028830B2Antibodies to CD122TSO J YUN·Filed 2011·Granted May 12, 2015·21 cites·13 claims
- 1290US10851173B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2018·Granted Dec 1, 2020·3 cites·12 claims
- 1390US8597647B1Humanized anti-IL-20 antibody and uses thereofCHANG MING-SHI·Filed 2012·Granted Dec 3, 2013·12 cites·15 claims
- 1490US7591913B2Thermoelectric properties by high temperature annealingMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Sep 22, 2009·8 cites·23 claims
- 1589US8986697B2Antibodies for the treatment of Clostridium difficile-associated infection and diseaseMA DANGSHE·Filed 2011·Granted Mar 24, 2015·23 cites·24 claims
- 1689US8629257B2IL-12/p40 binding proteinsLACY SUSAN E·Filed 2010·Granted Jan 14, 2014·18 cites·33 claims
- 1787US11344621B2Interleukin-13 binding proteinsABBVIE INC·Filed 2018·Granted May 31, 2022·2 cites·35 claims
- 1886US10086076B2Interleukin-13 binding proteinsABBVIE INC·Filed 2017·Granted Oct 2, 2018·4 cites·11 claims
- 1984US7442777B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2006·Granted Oct 28, 2008·6 cites·5 claims
- 2084US7223393B2Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2004·Granted May 29, 2007·16 cites·6 claims
- 2180US8821863B2Humanized anti-α 9 integrin antibodies and the uses thereofKUMAR SHANKAR·Filed 2009·Granted Sep 2, 2014·4 cites·2 claims
- 2280US8017118B2Anti-hDlk-1 antibody having an antitumor activity in vivoLIVTECH INC & MDASH TEIKYO UNIVERSITY BIOTECHNOLOGY RES CT·Filed 2009·Granted Sep 13, 2011·6 cites·8 claims
- 2378US8604177B2Interleukin-13 binding proteinsWU CHENGBIN·Filed 2011·Granted Dec 10, 2013·3 cites·30 claims
- 2471US9303086B2Anti-hDlk-1 antibody having an antitumor activity in vivoLIVTECH INC·Filed 2013·Granted Apr 5, 2016·1 cites·25 claims
- 2569US10202461B2Anti-human TROP-2 antibody having an antitumor activity in vivoCHIOME BIOSCIENCE INC·Filed 2016·Granted Feb 12, 2019·1 cites·14 claims
- 2664US10196450B2Anti-OX40 antibodies and methods of using the sameUNIV TEXAS·Filed 2017·Granted Feb 5, 2019·0 cites·11 claims
- 2764US2023287093A1Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodiesPINTEON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2863US11591385B2Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodiesPINTEON THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·0 cites·9 claims
- 2962US9683036B2Humanized anti-IL-20 antibody and uses thereofUNIV NAT CHENG KUNG·Filed 2013·Granted Jun 20, 2017·0 cites·17 claims
- 3056US2014178332A1IL-12/p40 BINDING PROTEINSABBVIE INC·Filed 2014·Application pending·0 cites
- 3155US2009155262A1Cytotoxicity mediation of cells evidencing surface expression of CD63YOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 3255US2008226632A1Amphiregulin antibodies and their use to treat cancer and psoriasisPDL BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 3353US8614296B2Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereofKUMAR SHANKAR·Filed 2009·Granted Dec 24, 2013·0 cites·10 claims
- 3453US2004260068A1Humanized chicken antibodiesFiled 2004·Application pending·0 cites
- 3545US8617829B2Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereofKUMAR SHANKAR·Filed 2010·Granted Dec 31, 2013·0 cites·7 claims
- 3642US8735552B2Generation, expression and characterization of the humanized K33N monoclonal antibodyKUMAR SHANKAR·Filed 2010·Granted May 27, 2014·0 cites·2 claims
- 3742US2015004178A1Anti-human sema4a antibodies useful to treat diseaseUNIV TEXAS·Filed 2012·Application pending·0 cites
- 3839US2015175681A1Antibodies for the treatment of clostridium difficile-associated infection and diseasePROGENICS PHARM INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →